Single cell proteogenomic analysis of aberrant monocytosis in TET2 mutant premalignant and malignant hematopoiesis

[1]  A. Tefferi,et al.  Clonal compositions involving epigenetic regulator and splicing mutations in CHIP, CCUS, MDS, and CMML. , 2022, Leukemia research.

[2]  Julie G. Burel,et al.  The Challenge of Distinguishing Cell–Cell Complexes from Singlet Cells in Non‐Imaging Flow Cytometry and Single‐Cell Sorting , 2020, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[3]  Julie G. Burel,et al.  The challenge of distinguishing cell-cell complexes from singlet cells in non-imaging flow cytometry and single-cell sorting , 2020, bioRxiv.

[4]  E. Solary,et al.  Clinical, molecular, and prognostic correlates of number, type, and functional localization of TET2 mutations in chronic myelomonocytic leukemia (CMML)—a study of 1084 patients , 2019, Leukemia.

[5]  A. Tefferi,et al.  Chronic Myelomonocytic leukemia: 2020 update on diagnosis, risk stratification and management , 2019, American journal of hematology.

[6]  T. D. de Gruijl,et al.  Thrombomodulin-expressing monocytes are associated with low-risk features in myelodysplastic syndromes and dampen excessive immune activation , 2019, Haematologica.

[7]  Julie G. Burel,et al.  Circulating T cell-monocyte complexes are markers of immune perturbations , 2019, eLife.

[8]  E. Solary,et al.  A miR-150/TET3 pathway regulates the generation of mouse and human non-classical monocyte subset , 2018, Nature Communications.

[9]  A. Harrington,et al.  Immunophenotypes of Chronic Myelomonocytic Leukemia (CMML) Subtypes by Flow Cytometry:  A Comparison of CMML-1 vs CMML-2, Myeloproliferative vs Dysplastic, De Novo vs Therapy-Related, and CMML-Specific Cytogenetic Risk Subtypes. , 2016, American journal of clinical pathology.

[10]  Mario Cazzola,et al.  The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. , 2016, Blood.

[11]  M. Stratton,et al.  Mutation allele burden remains unchanged in chronic myelomonocytic leukaemia responding to hypomethylating agents , 2016, Nature Communications.

[12]  E. Solary,et al.  Characteristic repartition of monocyte subsets as a diagnostic signature of chronic myelomonocytic leukemia. , 2015, Blood.

[13]  Piero Carninci,et al.  Transcription and enhancer profiling in human monocyte subsets. , 2014, Blood.

[14]  E. Solary,et al.  Clonal architecture of chronic myelomonocytic leukemias. , 2013, Blood.

[15]  Peter A. Jones,et al.  Epigenetics in cancer. , 2010, Carcinogenesis.